42 — The Biological Differential Diagnosis of Mental Illness

Abstract

Psychiatric syndromes can conceal endocrine, neurological, immune, nutritional, medication-related and metabolic causes. A biological differential diagnosis should therefore accompany symptom classification where the clinical presentation supplies reason. The thesis is that specific red flags and temporal patterns allow clinicians to identify actionable causes without turning every mental symptom into an indiscriminate search for exotic disease.

From a symptom label to a ranked causal explanation

The timing of illness, fluctuating attention, seizures, weight change, fever, exposure history and focal neurological signs can dramatically alter diagnostic priorities. A patient with new psychosis and seizures requires a different work-up from a person with a long, stable psychiatric course and no neurological change. Testing should resolve a relevant diagnostic fork rather than generate endless incidental abnormalities. This approach honors both the seriousness of primary psychiatric illness and the danger of missed reversible medical causes.

Oxalate assessment belongs in the differential only where documented renal stones, known hyperoxaluria, fat malabsorption, unusual exposures or systemic illness create a plausible pathway. Its place should grow if studies identify a distinctive neuropsychiatric phenotype. That is how a frontier hypothesis can become clinically operational: through improved discrimination, not through compulsory testing of everyone with anxiety or depression.

Begin with the syndrome, not the favorite mechanism

The first task is to identify what is actually happening: depressed mood, psychosis, mania, delirium, cognitive decline, dissociation, anxiety or a combination. Time course is as informative as symptom content. Abrupt change over hours or days, impaired attention, altered consciousness, focal neurological signs, seizures or severe systemic illness can alter clinical urgency. Long-standing affective symptoms with preserved cognition and stable physical health carry a different prior probability of encephalopathy or rare metabolic disease.

Organize plausible causal families

The principal medical categories include thyroid and parathyroid disorders; electrolyte and osmotic disturbances; hepatic and renal encephalopathy; nutritional deficiencies; medication and substance effects; epilepsy and structural neurological disease; autoimmune encephalitis; selected infections; and rare inherited metabolic conditions such as acute porphyria or Wilson disease. Pregnancy and postpartum transitions warrant additional consideration of reproductive hormones, sleep, bipolar vulnerability and rare neurological causes. None of these categories can be diagnosed from psychiatric symptoms alone.

Testing must answer a question

A laboratory finding becomes meaningful through its relationship to the clinical presentation. Serum sodium helps when acute confusion suggests osmotic disturbance; renal chemistry is relevant in systemic illness; thyroid studies may clarify a compatible endocrine picture. Indiscriminate panels can generate incidental findings and unnecessary interventions. A normal common screening test also does not exclude every rare disease; suspicion must depend on the specific phenotype rather than a checklist of all possible disorders.

Where oxalate belongs

In a patient with recurrent kidney stones, enteric malabsorption, kidney failure or known hyperoxaluria, oxalate physiology can be relevant. For isolated anxiety or psychosis without renal disease, evidence does not support routine oxalate attribution. The proposed OANVH should therefore occupy a narrowly qualified investigative position, not a mandatory diagnostic branch. Its proper place in clinical reasoning is lower than better-established and more plausible alternative causes until discriminating evidence emerges.

Coexistence and urgent care

A patient can have bipolar disorder and thyroid disease, schizophrenia and epilepsy, depression and a nutrient deficiency, or severe psychiatric illness alongside entirely normal routine laboratories. Treating one does not erase the other. Suspected delirium, encephalitis, seizures, rapidly evolving psychosis or postpartum psychosis requires timely qualified medical and psychiatric care. The aim of integration is to shorten dangerous diagnostic delay, not to obstruct established treatment with endless speculative testing.

A clinical reasoning sequence rather than a universal panel

The first branch of a responsible framework concerns acute safety and neurological instability. Severe confusion, impaired attention, seizure activity, rapidly progressive neurological findings, suicidal or violent risk and postpartum psychosis require prompt assessment. The second branch concerns the most likely and treatable common conditions, guided by history and examination: medication effects, intoxication, withdrawal, sleep deprivation, endocrine disease, infection or metabolic derangement. Only then should unusual inherited or autoimmune processes be considered according to their specific warning signs.

This sequence is not meant to suppress curiosity about rare mechanisms. It is a safeguard against opportunity cost. Every unhelpful test consumes time, introduces incidental findings and may divert attention from a more probable treatable condition. Conversely, a rare illness with a coherent constellation of signs deserves investigation even if routine screening is unrevealing. The task is to change probabilities with evidence, not to generate an endless catalogue of hidden causes.

Differential diagnosis is a causal argument

A biological differential diagnosis of psychiatric symptoms is not an indiscriminate hunt for abnormal laboratory numbers. It is an ordered comparison of mechanisms capable of producing a particular clinical phenotype in the person being evaluated. Acute confusion differs from sustained low mood; rapidly evolving hallucinations with seizures differ from an otherwise stable psychotic disorder; severe insomnia with mania shortly after childbirth differs from chronic generalized anxiety. These distinctions determine which possibilities deserve immediate priority and which exploratory hypotheses might be considered later. Without syndromic precision, even an extensive laboratory workup can create noise instead of understanding.

Metabolic and endocrine diseases provide concrete mimics. Thyroid abnormalities, severe calcium disturbances, hyperammonemia, porphyric attacks, B12 or thiamine deficiency and hyponatremia can all produce neurological or psychiatric manifestations in appropriate contexts. Autoimmune encephalitis and seizure disorders provide further neurological pathways. Medication effects and withdrawal can produce new psychiatric symptoms that mimic progression of an underlying disorder. The role of the clinician is to assess probability using time course, medical history, neurological examination and appropriately chosen tests rather than assume that any one of these causes explains every case.

Where an oxalate assessment might belong

The oxalate–brain hypothesis deserves consideration when the patient has independently meaningful evidence of oxalate-associated physiology: recurrent calcium oxalate stones, enteric hyperoxaluria, primary hyperoxaluria, severe fat malabsorption or unexplained kidney injury with credible oxalate findings. These contexts establish a stronger prior basis for investigation than nonspecific anxiety, fatigue or dietary preference alone. A person with objective hyperoxaluria and cognitive changes may warrant careful evaluation of renal function, systemic metabolic disturbance and nutritional comorbidity. It would still be premature to assume that oxalate directly caused the psychiatric manifestation.

For someone presenting with sudden psychosis, delirium or a dangerous change in behavior, urgent medical and psychiatric evaluation comes first. Oxalate testing is not part of a validated universal psychiatric emergency panel, and a low-oxalate diet is not a substitute for emergency treatment. Preserving this boundary does not trivialize the theory. It prevents a research program from becoming a clinical distraction precisely when time matters most.

Information that changes the diagnosis

A strong differential asks what finding would raise or lower each hypothesis. Severe hypercalcemia changes the probability of a mineral-mediated syndrome. A marked thyroid abnormality with characteristic clinical signs changes the probability of endocrine contribution. A stereotyped brief episode with altered awareness changes the probability of epilepsy. Confirmed hyperoxaluria with progressive kidney impairment makes renal-mediated neurological effects more plausible. Normal renal function and absent oxalate-specific history lower the prior plausibility of a severe oxalate-mediated mechanism but do not provide definitive evidence about every potential subtle pathway.

The wider lesson is that mechanistic explanations compete. A good clinician can remain open to unconventional causes while ranking ordinary ones and retaining the power to abandon an attractive hypothesis. The point of terrain medicine should be to broaden the causal map without erasing the value of established diagnoses and timely treatment. The quality of the map is measured by how well it predicts reality and improves care, not how many possible causes it contains.

A sample clinical reasoning sequence

A person reports new hallucinations after several days of insomnia. The first task is to establish whether consciousness and attention are altered, whether manic symptoms are present, and whether there are neurological signs, substance exposures or medication changes. A history of seizures would raise one set of possibilities; a postpartum transition another; fever and rapid cognitive decline another. Laboratory and other investigations follow the clinical findings. If the person also reports kidney stones or steatorrhea, oxalate-associated medical illness may be relevant, but that finding does not supplant urgent assessment for more established causes of acute change.

Prior probability is not closed-mindedness

An established thyroid disorder has a different evidentiary status from an unvalidated claim that ordinary dietary oxalate causes hallucinations. Taking both seriously does not mean assigning both equal probability. The point of the differential is to compare mechanisms according to known disease frequency, fit to the presentation and quality of supporting data. If new evidence of abnormal oxalate handling emerges, the estimate can change. Scientific openness means allowing strong observations to revise probabilities, not refusing to rank hypotheses. The same approach can prevent unnecessary tests and interventions while preserving space for discovery.

Conclusion

An integrated differential is an argument about causes, not a shopping list of laboratory tests. It should be rigorous enough to find established medical disease and flexible enough to recognize a genuinely new mechanism when the evidence appears.

Selected readings

Pollak et al., Autoimmune psychosis consensus: https://pubmed.ncbi.nlm.nih.gov/31669058/

Wilson disease psychiatric manifestations: https://pmc.ncbi.nlm.nih.gov/articles/PMC6022881/

Hypothyroidism presenting as psychosis: https://pmc.ncbi.nlm.nih.gov/articles/PMC419396/

Acute intermittent porphyria psychiatric manifestations: https://pmc.ncbi.nlm.nih.gov/articles/PMC4923792/